Organ Transplant Immunosuppressant Drugs Market Size, Share, Trends, Growth and Forecast 2025

Organ Transplant Immunosuppressant Drugs Market

Organ Transplant Immunosuppressant Drugs Market by Drug Class (Antibodies, Steroids, mTOR Inhibitor, Antiproliferative Agents and Calcineurin Inhibitors); by Transplant Type (Pancreas, Lung, Heart, Liver, Kidney and Other); by Distribution Channel (Online Pharmacies, Retail Pharmacies and Hospital Pharmacies): Global Industry Perspective, Comprehensive Analysis and Forecast, 2018 - 2025

Category: Pharmaceutical Report Format : PDF Pages: 126 Report Code: ZMR-5014 Published Date: Nov-2019 Status : Published
Market Size in 2018 Market Forecast in 2025 CAGR (in %) Base Year
USD 4.51 Billion USD 5.79 Billion 3.7% 2018

Organ Transplant Immunosuppressant Drugs Market

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
    • 2.2. Organ Transplant Immunosuppressant Drugs Market: Snapshot
  • Chapter 3. Organ Transplant Immunosuppressant Drugs Market - Industry Analysis
    • 3.1. Organ Transplant Immunosuppressant Drugs Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Driver 1
      • 3.2.2. Driver 2
    • 3.3. Restraints
      • 3.3.1. Restraint 1
      • 3.3.2. Restraint 2
    • 3.4. Opportunity
      • 3.4.1. Government funding and support
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis By Product
      • 3.6.2. Market attractiveness analysis By Transplant Type
      • 3.6.3. Market attractiveness analysis By Distribution Channel
      • 3.6.4. Market attractiveness analysis By Region
  • Chapter 4. Organ Transplant Immunosuppressant Drugs Market- Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Organ Transplant Immunosuppressant Drugs Market: company market share, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Organ Transplant Immunosuppressant Drugs Market - Drug Class Analysis
    • 5.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Drug Class
      • 5.1.1. Global Organ Transplant Immunosuppressant Drugs Market share, By Product,2018 and 2025
    • 5.2. Calcineurin Inhibitors
      • 5.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Product1, 2016-2025 (USD Million)
    • 5.3. Antiproliferative Agents
      • 5.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Product2, 2016-2025 (USD Million)
    • 5.4. mTOR Inhibitor
      • 5.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Product3, 2016-2025 (USD Million)
    • 5.5. Steroids
      • 5.5.1. Global Organ Transplant Immunosuppressant Drugs Market By Product4, 2016-2025 (USD Million)
    • 5.6. Antibodies
      • 5.6.1. Global Organ Transplant Immunosuppressant Drugs Market By Antibodies, 2016-2025 (USD Million)
  • Chapter 6. Global Organ Transplant Immunosuppressant Drugs Market -Transplant Type Analysis
    • 6.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Transplant Type
      • 6.1.1. Global Organ Transplant Immunosuppressant Drugs Market share, By Transplant Type, 2018 and 2025
    • 6.2. Kidney
      • 6.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Kidney, 2016-2025 (USD Million)
    • 6.3. Liver
      • 6.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Liver, 2016-2025 (USD Million)
    • 6.4. Heart
      • 6.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Heart, 2016-2025 (USD Million)
    • 6.5. Lung
      • 6.5.1. Global Organ Transplant Immunosuppressant Drugs Market By Lung, 2016-2025 (USD Million)
    • 6.6. Pancreas
      • 6.6.1. Global Organ Transplant Immunosuppressant Drugs Market By PancreasTransplant Types, 2016-2025 (USD Million)
    • 6.7. Others
      • 6.7.1. Global Organ Transplant Immunosuppressant Drugs Market By Other Transplant Types, 2016-2025 (USD Million)
  • Chapter 7. Global Organ Transplant Immunosuppressant Drugs Market -Distribution Channel Analysis
    • 7.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Distribution Channel
      • 7.1.1. Global Organ Transplant Immunosuppressant Drugs Marketshare, By Distribution Channel, 2018 and 2025
    • 7.2. Hospital Pharmacies
      • 7.2.1. Global Organ Transplant Immunosuppressant Drugs Market By Hospital Pharmacies, 2016-2025 (USD Million)
    • 7.3. Retail Pharmacies
      • 7.3.1. Global Organ Transplant Immunosuppressant Drugs Market By Retail Pharmacies, 2016-2025 (USD Million)
    • 7.4. Online Pharmacies
      • 7.4.1. Global Organ Transplant Immunosuppressant Drugs Market By Online Pharmacies, 2016-2025 (USD Million)
  • Chapter 8. Global Organ Transplant Immunosuppressant Drugs Market - Regional Analysis
    • 8.1. Global Organ Transplant Immunosuppressant Drugs Market overview: By Region
      • 8.1.1. Global Organ Transplant Immunosuppressant Drugs Marketshare, By Region, 2018 and 2025
    • 8.2. North America
      • 8.2.1. North America Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.2.2. North America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.2.3. North America Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.2.4. North America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.5. The U.S.
        • 8.2.5.1. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.5.2. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.2.5.3. The U.S.Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.2.6. Rest of North America
        • 8.2.6.1. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.2.6.2. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.2.6.3. Rest of North America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.3. Europe
      • 8.3.1. EuropeOrgan Transplant Immunosuppressant Drugs Market2016-2025 (USD Million)
      • 8.3.2. Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.3.3. Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.3.4. Europe Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.5. UK
        • 8.3.5.1. U.K.Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.5.2. U.K.Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.5.3. U.K. Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.6. France
        • 8.3.6.1. France Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.6.2. France Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.6.3. France Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.7. Germany
        • 8.3.7.1. Germany Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.7.2. Germany Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.7.3. Germany Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.3.8. Rest of Europe
        • 8.3.8.1. Rest of EuropeOrgan Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.3.8.2. Rest of EuropeOrgan Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.3.8.3. Rest of Europe Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.4. Asia Pacific
      • 8.4.1. Asia Pacific Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.4.2. Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.4.3. Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.4.4. Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.5. China
        • 8.4.5.1. China Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.5.2. China Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.5.3. China Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.6. Japan
        • 8.4.6.1. Japan Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.6.2. Japan Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.6.3. Japan Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.7. India
        • 8.4.7.1. India Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.4.7.2. India Organ Transplant Immunosuppressant Drugs Marketrevenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.7.3. India Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.4.8. Rest of Asia Pacific
        • 8.4.8.1. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.4.8.2. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.4.8.3. Rest of Asia Pacific Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.5. Latin America
      • 8.5.1. Latin America Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.5.2. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
      • 8.5.3. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.5.4. Latin America Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.5. Brazil
        • 8.5.5.1. Brazil Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
        • 8.5.5.2. Brazil Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.5.5.3. Brazil Organ Transplant Immunosuppressant Drugs Market revenue, By Distribution Channel, 2016-2025 (USD Million)
      • 8.5.6. Rest of LatinAmerica
        • 8.5.6.1. Rest of LatinAmerica Organ Transplant Immunosuppressant Drugs Market revenue, By Product,2016-2025 (USD Million)
        • 8.5.6.2. Rest of LatinAmerica Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
        • 8.5.6.3. Rest of Latin America Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
    • 8.6. The Middle East and Africa
      • 8.6.1. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market, 2016-2025 (USD Million)
      • 8.6.2. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Marketrevenue, By Product,2016-2025 (USD Million)
      • 8.6.3. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Market revenue, By Transplant Type, 2016-2025 (USD Million)
      • 8.6.4. The Middle East and Africa Organ Transplant Immunosuppressant Drugs Marketrevenue, By Distribution Channel, 2016-2025 (USD Million)
  • Chapter 9. Company Profiles
    • 9.1. Bristol-Myers Squibb Company
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfolio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. Veloxis Pharmaceuticals A/S
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfolio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. GlaxoSmithKline plc
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfolio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Developments
    • 9.4. Dr. Reddy's Laboratories Ltd
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfolio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Developments
    • 9.5. F. Hoffmann-La Roche Ltd
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfolio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Mylan Laboratories, Inc.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfolio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Novartis AG
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfolio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. Accord Healthcare Ltd.
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfolio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development
    • 9.9. Sanofi Genzyme
      • 9.9.1. Overview
      • 9.9.2. Financials
      • 9.9.3. Product Portfolio
      • 9.9.4. Business Strategy
      • 9.9.5. Recent Development
    • 9.10. Astellas Pharma, Inc.
      • 9.10.1. Overview
      • 9.10.2. Financials
      • 9.10.3. Product Portfolio
      • 9.10.4. Business Strategy
      • 9.10.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
4. Porter’s five forces analysis: organ transplant immunosuppressant drugs market
5. Global organ transplant immunosuppressant drugs market attractiveness, by drug class
6. Global organ transplant immunosuppressant drugs market attractiveness, by transplant type
7. Global organ transplant immunosuppressant drugs market attractiveness, by distribution channel
8. Global organ transplant immunosuppressant drugs market revenue share, by drug class, 2018 and 2025
9. Global organ transplant immunosuppressant drugs market by Calcineurin Inhibitors, 2016-2025 (USD Million)
10. Global organ transplant immunosuppressant drugs market by Antiproliferative Agents, 2016-2025 (USD Million)
11. Global organ transplant immunosuppressant drugs market by mTOR Inhibitor, 2016-2025 (USD Million)
12. Global organ transplant immunosuppressant drugs market by Steroids, 2016-2025 (USD Million)
13. Global organ transplant immunosuppressant drugs market by Antibodies, 2016-2025 (USD Million)
14. Global organ transplant immunosuppressant drugs market revenue share, by transplant type, 2018 and 2025
15. Global organ transplant immunosuppressant drugs market by Kidney, 2016-2025 (USD Million)
16. Global organ transplant immunosuppressant drugs market by Liver, 2016-2025 (USD Million)
17. Global organ transplant immunosuppressant drugs market by Heart, 2016-2025 (USD Million)
18. Global organ transplant immunosuppressant drugs market by Lung, 2016-2025 (USD Million)
19. Global organ transplant immunosuppressant drugs market by Pancreas, 2016-2025 (USD Million)
20. Global organ transplant immunosuppressant drugs market by Others, 2016-2025 (USD Million)
21. Global organ transplant immunosuppressant drugs market revenue share, by distribution channel, 2018 and 2025
22. Global organ transplant immunosuppressant drugs market by Hospital Pharmacies, 2016-2025 (USD Million)
23. Global organ transplant immunosuppressant drugs market by Retail Pharmacies, 2016-2025 (USD Million)
24. Global organ transplant immunosuppressant drugs market by Online Pharmacies, 2016-2025 (USD Million)
25. Global organ transplant immunosuppressant drugs market revenue share, by region, 2018 & 2025
26. North America organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
27. Europe organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
28. Asia Pacific organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
29. Latin America organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
30. Middle East & Africa organ transplant immunosuppressant drugs market, 2016-2025 (USD Million)
 
 


Table Of Tables

List of Tables

1. Global organ transplant immunosuppressant drugs market: snapshot
2. Drivers for organ transplant immunosuppressant drugs market: impact analysis
3. Restraints for organ transplant immunosuppressant drugs market: impact analysis
4. North America organ transplant immunosuppressant drugs market revenue, by country, 2016-2025 (USD Million)
5. North America organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
6. North America organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
7. North America organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
8. The U.S. organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
9. The U.S. organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
10. The U.S. organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
11. Rest of North America organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
12. Rest of North America organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
13. Rest of North America organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
14. Europe organ transplant immunosuppressant drugs market revenue, by country, 2016-2025 (USD Million)
15. Europe organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
16. Europe organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
17. Europe organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
18. U.K. organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
19. U.K. organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
20. U.K. organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
21. France organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
22. France organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
23. France organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
24. Germany organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
25. Germany organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
26. Germany organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
27. Rest of Europe organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
28. Rest of Europe organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
29. Rest of Europe organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
30. Asia Pacific organ transplant immunosuppressant drugs market revenue, by country, 2016-2025 (USD Million)
31. Asia Pacific organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
32. Asia Pacific organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
33. Asia Pacific organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
34. China organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
35. China organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
36. China organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
37. Japan organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
38. Japan organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
39. Japan organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
40. India organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
41. India organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
42. India organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
43. Rest of Asia Pacific organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
44. Rest of Asia Pacific organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
45. Rest of Asia Pacific organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
46. Latin America organ transplant immunosuppressant drugs market revenue, by country, 2016-2025 (USD Million)
47. Latin America organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
48. Latin America organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
49. Latin America organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
50. Brazil organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
51. Brazil organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
52. Brazil organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
53. Rest of Latin America organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
54. Rest of Latin America organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
55. Rest of Latin America organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
56. Middle  East & Africa organ transplant immunosuppressant drugs market revenue, by drug class, 2016-2025 (USD Million)
57. Middle  East & Africa organ transplant immunosuppressant drugs market revenue, by transplant type, 2016-2025 (USD Million)
58. Middle  East & Africa organ transplant immunosuppressant drugs market revenue, by distribution channel, 2016-2025 (USD Million)
 

Methodology

FrequentlyAsked Questions

Global demand for organ transplant immunosuppressant drugs market was valued at approximately USD 4.51 billion in 2018 and is expected to generate revenue of around USD 5.79 billion by end of 2025

Bristol-Myers Squibb Company, Veloxis Pharmaceuticals A/S, GlaxoSmithKline plc, Dr. Reddy’s Laboratories Ltd., F. Hoffmann-La Roche Ltd., Mylan Laboratories, Inc., Novartis AG, Accord Healthcare Ltd., Sanofi Genzyme, and Astellas Pharma, Inc. among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed